The trademark application ENDOSID was filed by Medline Industries, LP, a U.S. corporation (the "Applicant"). The application was published for oppositions on November 26, 2023, and it was registered by office on March 4, 2024 without any oppositions.
The application was filed in English (German was selected as the second language).